ARS Pharmaceuticals
Needle-free epinephrine nasal spray for severe allergic reactions
- Sector
- Medtech
- Headquarters
- SAN DIEGO, CA
- Founded
- 2015
- Latest Form D
- $55M, Sep 2021
- Total capital
- $63M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $63M
- 2 Form D · last Sep 2021
- 62 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 5 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$55M
- Private capital raisedForm D · SEC · 1st filing$8M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Brent SaundersDirectorNamed in SEC Form D filings
- Dana McGowanExecutive OfficerNamed in SEC Form D filings
- Jonathan LeffDirectorNamed in SEC Form D filings
- Mike KellyDirectorNamed in SEC Form D filings
- Peter KolchinskyDirectorNamed in SEC Form D filings
- Phil SchneiderDirectorNamed in SEC Form D filings
Show all 9 people
- Pratik ShahDirectorNamed in SEC Form D filings
- Rajeev DadooDirectorNamed in SEC Form D filings
- Richard LowenthalExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 5- PendingIntranasal Epinephrine Formulations And Methods Of UseUSPTOApplication 63555207
- PendingANTI-ASGR1 Antibody Conjugates And Uses ThereofUSPTOApplication PCTUS2021039974
- PendingIntranasal Epinephrine Formulations And Methods For The Treatment Of DiseaseUSPTOApplication PCTUS2019016918
Show all 5 patent records
- Intranasal Epinephrine Formulations And Methods Of UseApplication 63555207Pending
- ANTI-ASGR1 Antibody Conjugates And Uses ThereofApplication PCTUS2021039974Pending
- Intranasal Epinephrine Formulations And Methods For The Treatment Of DiseaseApplication PCTUS2019016918Pending
- Intranasal Epinephrine Formulations And Methods For The Treatment Of DiseaseApplication 62784057Pending
- ALK5 Inhibitors, Conjugates, And Uses ThereofApplication 18003665Pending
Related companies, and why
- Geneticure Inc.Similar federal contract value in Medtech · null in contracts
- Voyce, Inc.Similar federal contract value in Medtech · null in contracts
- EDEN MEDICAL, INC.Similar federal contract value in Medtech · null in contracts
- TMRW Life Sciences Holdings, LLCSimilar federal contract value in Medtech · null in contracts
- Nascent Surgical Holdings, LLCSimilar federal contract value in Medtech · null in contracts
- Corvia MedicalSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .